N-[2-[2-chloro-5-(furan-2-carbonylamino)phenyl]-1H-imidazo[4,5-b]pyridin-6-yl]piperidine-4-carboxamide
C23H21ClN6O3 — CID 85471524
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[2-chloro-5-(furan-2-carbonylamino)phenyl]-1H-imidazo[4,5-b]pyridin-6-yl]piperidine-4-carboxamide
N-[2-[2-chloro-5-(furan-2-carbonylamino)phenyl]-1H-imidazo[4,5-b]pyridin-6-yl]piperidine-4-carboxamide (PubChem CID 85471524) has the molecular formula C23H21ClN6O3 and a molecular weight of 464.91 g/mol. Its IUPAC name is N-[2-[2-chloro-5-(furan-2-carbonylamino)phenyl]-1H-imidazo[4,5-b]pyridin-6-yl]piperidine-4-carboxamide.
Molecular Properties
| Compound Name | N-[2-[2-chloro-5-(furan-2-carbonylamino)phenyl]-1H-imidazo[4,5-b]pyridin-6-yl]piperidine-4-carboxamide |
|---|---|
| PubChem CID | 85471524 |
| Molecular Formula | C23H21ClN6O3 |
| Molecular Weight | 464.91 g/mol |
| Exact Mass | 464.14 |
| IUPAC Name | N-[2-[2-chloro-5-(furan-2-carbonylamino)phenyl]-1H-imidazo[4,5-b]pyridin-6-yl]piperidine-4-carboxamide |
| SMILES | O=C(Nc1ccc(Cl)c(-c2nc3ncc(NC(=O)C4CCNCC4)cc3[nH]2)c1)c1ccco1 |
| InChI | InChI=1S/C23H21ClN6O3/c24-17-4-3-14(27-23(32)19-2-1-9-33-19)10-16(17)20-29-18-11-15(12-26-21(18)30-20)28-22(31)13-5-7-25-8-6-13/h1-4,9-13,25H,5-8H2,(H,27,32)(H,28,31)(H,26,29,30) |
| InChIKey | LKYWICGQPKLXGX-UHFFFAOYSA-N |
| XLogP | 4.06 |
| TPSA | 124.94 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 464.91 |
| LogP ≤ 5 | 4.06 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 85471524 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.